High Flow Nasal Cannula Rates in Pediatric Asthma
Key facts
- Who runs it
- University of Rochester
- Where
- Rochester, United StatesSee the 2 sites
- Trial code
- Status
- Withdrawn
- Started
- 15 Jan 2025
- Ended
- 30 Sept 2026
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- "High Flow" High Flow Nasal Cannula
- "Low Flow" High Flow Nasal Cannula
- Record updated
- 27 March 2026
- Why it stopped
- No longer performing study due to lack of funding and protected research time by PI
Who can take part
- Age
- 2 years to 17 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age 2-17 years old with prior clinical diagnosis of asthma
- Admitted to PICU on standard asthma therapy defined as continuous albuterol and systemic corticosteroids
- Admitted to PICU on either COT or HFNC
- Admitted to PICU from either Golisano Children's Hospital ED or as a transport from an outside hospital ED within 6 hours of initial presentation
- PRAM score greater than or equal to 4 after completion of initial ED therapy
Who cannot take part
- Admitted to the PICU on NIV or invasive mechanical ventilation
- Admitted to the PICU from general floors or > 6 hours from initial presentation
- Presence of a tracheostomy or baseline NIV requirement
- Pregnancy
- Immunocompromised State
Where in United States
- University of Rochester / Golisano Children's HospitalRochester, United States
- University of Rochester Medical CenterRochester, United States
About the trial
What the trial wants to find out
This is a randomized, open-label, 3-armed feasibility trial will examine conventional oxygen therapy (COT) vs high flow nasal cannula at 4L/min flow vs HFNC at 2L/kg/min flow (max 60L/min) in moderate to severe pediatric asthma exacerbations.
The 3 groups in the trial
- Conventional Oxygen Therapy (COT)No study treatment, for comparison
Conventional Oxygen Therapy (COT) is the standard way to deliver oxygen to hypoxemic pediatric patients during an acute asthma exacerbation. Continuous albuterol will be administered via an aerogen set-up (aerogen mask, aerogen ultra, and a vibrating mesh nebulizer). Oxygen tubing will be connected to the wall and run at 2L/min as per the aerogen manufacturer's instructions.
- "Low Flow" High Flow Nasal Cannula at 4L/minTreatment being tested
A Fisher Paykl humidifier will be used for high flow humidification along with a flow meter and oxygen blender. A vibrating mesh nebulizer will be connected between the flow meter and the humidifier as per routine practice. Oxygen flow will be set to 4L/min and patient will be fitted with appropriately sized nasal prongs.
Treatment: "Low Flow" High Flow Nasal Cannula
- "High Flow" High Flow Nasal Cannula at 2L/kg/min (max 60L/min)Treatment being tested
A Fisher Paykl humidifier will be used for high flow humidification along with a flow meter and oxygen blender. A vibrating mesh nebulizer will be connected between the flow meter and the humidifier as per routine practice. Oxygen flow will be set to 2L/kg/min (max 60L/min) and patient will be fitted with appropriately sized nasal prongs.
Treatment: "High Flow" High Flow Nasal Cannula
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- High Flow Nasal Cannula Rates in Pediatric Asthma Exacerbations: A Feasibility Study
- Record updated
- 27 March 2026